Kathy Whitney

January 15, 2015

New drugs approved to fight idiopathic pulmonary fibrosis

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

By Kathy Whitney
hamburger and fries
December 18, 2014

Gene regulators of circulating trans fatty acids identified

High consumption of trans fatty acids (TFA) has been linked to increased risk of heart disease, stroke and even cancer.

By Kathy Whitney
November 18, 2014

Vanderbilt University Medical Center offers surgical option for form of pulmonary hypertension

By Kathy Whitney
November 13, 2014

VUSM students land Sarnoff Foundation awards

Two Vanderbilt University School of Medicine students are among 11 individuals nationwide to receive Sarnoff Foundation Medical Student Research Fellowship awards for 2014-2015.

By Kathy Whitney
kidney x-ray
October 30, 2014

NIH grant spurs diabetic nephropathy research

Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.

By Kathy Whitney
October 16, 2014

Heart patient uses ICD experience to promote benefits of exercise

Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA).

By Kathy Whitney
October 9, 2014

Heart Institute celebrates implantation program success

Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart.
By Kathy Whitney
October 2, 2014

Program focuses on heart health of cancer patients

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.
By Kathy Whitney
October 2, 2014

VHVI screening brings heart care to young athletes

Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members.
By Kathy Whitney
September 18, 2014

These Doctors Mean Business: Med school graduates contributing in non-clinical roles

By Kathy Whitney
September 18, 2014

Heart Institute testing world’s tiniest pacemaker

Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker.
By Kathy Whitney
September 11, 2014

Nashville Heart Walk hits Vanderbilt campus on Oct. 4

The 2014 Greater Nashville Heart Walk will take place on Vanderbilt’s campus on Saturday, Oct. 4.
By Kathy Whitney
1 … 16 17 18 19 20 … 25